Product Information

ESTRING 7.5 MCG/DAY (2 MG) RING is a brand product labeled by Pfizer Inc., priced at $551.2890 per EA under NDC 00013104201. Its NADAC has been published 155 times since Jul 12, 2023.

The High Outlier badge above means this manufacturer's average price in the estradiol market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

ESTRING 7.5 MCG/DAY (2 MG) RING

estradiol
$551.2890per EA
High Outlier

Strength

2 mg/1

Manufacturer

Pfizer Inc.

NDC

00013104201

Classification

Brand

Dosage Form

SYSTEM

Route

VAGINAL

Last Updated

6/17/2026

Active Ingredients

ESTRADIOL

Approval Type

New Drug (NDA)

FDA Application

NDA020472

On Market Since

6/5/2023

Pharmacological Classes

Estradiol Congeners
Estrogen Receptor Agonists
Estrogen

Price Statistics

The NADAC for ESTRING 7.5 MCG/DAY (2 MG) RING has been published 155 times since Jul 12, 2023, and over the history we have for it it has risen 8.6%. The table below summarizes its recorded NADAC range and movement.

Current price$551.2890 per EA
All-time high$552.1545 (May 13, 2026)
All-time low$507.6062 (Sep 20, 2023)
52-week high$552.1545
52-week low$537.4210
Median price$524.6770
Average price$530.6184
Largest weekly change+3.0% (Jan 3, 2024)
Weeks tracked155
Tracking sinceJul 12, 2023

Price History

1W

0.0%

1M

+0.0%

3M

-0.2%

6M

+2.5%

1Y

+2.6%

3Y

N/A

5Y

N/A

All

+8.6%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the estradiol market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of ESTRING 7.5 MCG/DAY (2 MG) RING?

The current National Average Drug Acquisition Cost (NADAC) for ESTRING 7.5 MCG/DAY (2 MG) RING, manufactured by Pfizer Inc., is $551.2890 per EA (NDC 00013104201), effective Jun 24, 2026.

How has the price of ESTRING 7.5 MCG/DAY (2 MG) RING changed over time?

Over the history we have for it, the NADAC for ESTRING 7.5 MCG/DAY (2 MG) RING has risen 8.6%. It has been tracked across 155 weekly CMS publications since Jul 12, 2023.

What are the highest and lowest recorded NADAC prices for ESTRING 7.5 MCG/DAY (2 MG) RING?

Since Jul 12, 2023, the NADAC for ESTRING 7.5 MCG/DAY (2 MG) RING has ranged from a low of $507.6062 (Sep 20, 2023) to a high of $552.1545 (May 13, 2026), with a median of $524.6770 per EA.

Are there cheaper alternatives to ESTRING 7.5 MCG/DAY (2 MG) RING?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ESTRING 7.5 MCG/DAY (2 MG) RING, so no direct lower-cost alternative is listed.

Who manufactures ESTRING 7.5 MCG/DAY (2 MG) RING?

ESTRING 7.5 MCG/DAY (2 MG) RING (NDC 00013104201) is labeled by Pfizer Inc., and CMS classifies it as a brand product.